Evaluation of biofilm production and characterization of genes encoding type III secretion system among Pseudomonas aeruginosa isolated from burn patients

Burns

Volumn 38, Issue 8, 2012, Pages 1192-1197

  Jabalameli, Fereshteh ^a   Mirsalehian, Akbar ^a   Khoramian, Babak ^a   Aligholi, Marzieh ^a   Khoramrooz, Seyed Sajjad ^b   Asadollahi, Parisa ^c   Taherikalani, Morovat ^c   Emaneini, Mohammad ^a  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b YASUJ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c ILAM UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Biofilm production; Burn patients; Pseudomonas aeruginosa; Type III secretion system

Indexed keywords

AMIKACIN; AZTREONAM; CARBENICILLIN; CEFEPIME; CEFIXIME; CEFOTAXIME; CEFPODOXIME; CEFTRIAXONE; CIPROFLOXACIN; CYTOTOXIN; GATIFLOXACIN; GENTAMICIN; LEVOFLOXACIN; PIPERACILLIN PLUS TAZOBACTAM; POLYMYXIN B; TICARCILLIN; TOBRAMYCIN;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL GENE; BACTERIAL STRAIN; BACTERIUM ISOLATE; BIOFILM; BURN; COLORIMETRY; CONTROLLED STUDY; DISK DIFFUSION; GENE TARGETING; GENETIC CODE; HUMAN; HUMAN CELL; MICROTITER PLATE ASSAY; POLYMERASE CHAIN REACTION; PSEUDOMONAS AERUGINOSA; QUANTITATIVE ANALYSIS; TYPE III SECRETION SYSTEM; WOUND INFECTION;

ANTI-BACTERIAL AGENTS; BACTERIAL PROTEINS; BACTERIAL TOXINS; BIOFILMS; BURNS; DRUG RESISTANCE, MICROBIAL; EPITHELIAL CELLS; GENES, BACTERIAL; HUMANS; MICROBIAL SENSITIVITY TESTS; POLYMERASE CHAIN REACTION; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS;

EID: 84868208915     PISSN: 03054179     EISSN: 18791409     Source Type: Journal    
DOI: 10.1016/j.burns.2012.07.030     Document Type: Article

References (27)

1. J.L. Veesenmeyer, A.R. Hauser, T. Lisboa, and J. Rello Pseudomonas aeruginosa virulence and therapy: evolving translational strategies Crit Care Med 37 2009 1777 1786
2. F. Jabalameli, A. Mirsalehian, N. Sotoudeh, L. Jabalameli, M. Aligholi, and B. Khoramian Multiple-locus variable number of tandem repeats (VNTR) fingerprinting (MLVF) and antibacterial resistance profiles of extended spectrum beta lactamase (ESBL) producing Pseudomonas aeruginosa among burnt patients in Tehran Burns 37 2011 1202 1207
3. L.K. Branski, A. Al-Mousawi, H. Rivero, M.G. Jeschke, A.P. Sanford, and D.N. Herndon Emerging infections in burns Surg Infect (Larchmt) 10 2009 389 397
4. A. Roy-Burman, R.H. Savel, S. Racine, B.L. Swanson, N.S. Revadigar, and J. Fujimoto Type III protein secretion is associated with death in lower respiratory and systemic Pseudomonas aeruginosa infections J Infect Dis 183 2001 1767 1774
5. J. Engel, and P. Balachandran Role of Pseudomonas aeruginosa type III effectors in disease Curr Opin Microbiol 12 2009 61 66
6. H.H. Lin, S.P. Huang, H.C. Teng, D.D. Ji, Y.S. Chen, and Y.L. Chen Presence of the exoU gene of Pseudomonas aeruginosa is correlated with cytotoxicity in MDCK cells but not with colonization in BALB/c mice J Clin Microbiol 44 2006 4596 4597
7. V.T. Lee, R.S. Smith, B. Tümmler, and S. Lory Activities of Pseudomonas aeruginosa effectors secreted by the Type III secretion system in vitro and during infection Infect Immun 73 2005 1695 1705
8. A. Wong-Beringer, J. Wiener-Kronish, S. Lynch, and J. Flanagan Comparison of type III secretion system virulence among fluoroquinolone-susceptible and -resistant clinical isolates of Pseudomonas aeruginosa Clin Microbiol Infect 14 2008 330 336
9. A.R. Hauser The type III secretion system of Pseudomonas aeruginosa: infection by injection Nat Rev Microbiol 7 2009 654 665
10. A.A. Hammond, K.G. Miller, C.J. Kruczek, J. Dertien, J.A. Colmer-Hamood, and J.A. Griswold An in vitro biofilm model to examine the effect of antibiotic ointments on biofilms produced by burn wound bacterial isolates Burns 37 2011 312 321
11. M.S. Byrd, B. Pang, W. Hong, E.A. Waligora, R.A. Juneau, and C.E. Armbruster Direct evaluation of Pseudomonas aeruginosa biofilm mediators in a chronic infection model Infect Immun 79 2011 3087 3095
12. P. Kennedy, S. Brammah, and E. Wills Burns, biofilm and a new appraisal of burn wound sepsis Burns 36 2010 49 56
13. Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing; Twenty-First Informational Supplement. 2011; 31:M100-S21.
14. B. Fatholahzadeh, F.B. Hashemi, M. Emaneini, M. Aligholi, F.A. Nakhjavani, and B. Kazemi Detection of vancomycin resistant enterococci (VRE) isolated from urinary tract infections (UTI) in Tehran, Iran DARU J Pharm Sci 14 2006 141 145
15. H. Feltman, G. Schulert, S. Khan, M. Jain, L. Peterson, and A.R. Hauser Prevalence of type III secretion genes in clinical and environmental isolates of Pseudomonas aeruginosa Microbiology 147 Pt 10 2001 2659 2669
16. Y.Y. Chan, Y.M. Ong, and K.L. Chua Synergistic interaction between phenothiazines and antimicrobial agents against Burkholderia pseudomallei Antimicrob Agents Chemother 51 2007 623 630
17. B. Lee, C.K. Schjerling, N. Kirkby, N. Hoffmann, R. Borup, and S. Molin Mucoid Pseudomonas aeruginosa isolates maintain the biofilm formation capacity and the gene expression profiles during the chronic lung infection of CF patients Apmis 119 2011 263 274
18. S. Stepanović, D. Vuković, V. Hola, G. Di Bonaventura, S. Djukić, and I. Cirković Quantification of biofilm in microtiter plates: overview of testing conditions and practical recommendations for assessment of biofilm production by Staphylococci Apmis 115 2007 891 899
19. M.A. Bahar, S. Jamali, and A. Samadikuchaksaraei Imipenem-resistant Pseudomonas aeruginosa strains carry metallo-beta-lactamase gene bla (VIM) in a level I Iranian burn hospital Burns 36 2010 826 830
20. D.W. Wareham, and M.A. Curtis A genotypic and phenotypic comparison of type III secretion profiles of Pseudomonas aeruginosa cystic fibrosis and bacteremia isolates Int J Med Microbiol 297 2007 227 234
21. H. Sato, and D.W. Frank ExoU is a potent intracellular phospholipase Mol Microbiol 53 2004 279 290
22. T. Strateva, B. Markova, D. Ivanova, and I. Mitov Distribution of the type III effector proteins-encoding genes among nosocomial Pseudomonas aeruginosa isolates from Bulgaria Annals Microbiol 60 2010 503 550
23. K.W. Garey, Q.P. Vo, M.T. Larocco, L.O. Gentry, and V.H. Tam Prevalence of type III secretion protein exoenzymes and antimicrobial susceptibility patterns from bloodstream isolates of patients with Pseudomonas aeruginosa bacteremia J Chemother 20 2008 714 720
24. P. Berthelot, I. Attree, P. Plésiat, J. Chabert, S. de Bentzmann, and B. Pozzetto Genotypic and phenotypic analysis of type III secretion system in a cohort of Pseudomonas aeruginosa bacteremia isolates: evidence for a possible association between O serotypes and exo genes J Infect Dis 188 2003 512 518
25. A.A. El-Solh, A. Hattemer, A.R. Hauser, A. Alhajhusain, and H. Vora Clinical outcomes of type III Pseudomonas aeruginosa bacteremia Crit Care Med 40 2012 1157 1163
26. H. Zhu, T.C. Conibear, R. Bandara, Y. Aliwarga, F. Stapleton, and M.D. Willcox Type III secretion system-associated toxins, proteases, serotypes, and antibiotic resistance of Pseudomonas aeruginosa isolates associated with keratitis Curr Eye Res 31 2006 297 306
27. M.H. Choy, F. Stapleton, M.D. Willcox, and H. Zhu Comparison of virulence factors in Pseudomonas aeruginosa strains isolated from contact lens- and non-contact lens-related keratitis J Med Microbiol 57 Pt 12 2008 1539 1546